語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Non-Coding Variants in the Genomic A...
~
Sosa, Eric Alexander,
FindBook
Google Book
Amazon
博客來
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment // Eric Alexander Sosa.
作者:
Sosa, Eric Alexander,
面頁冊數:
1 electronic resource (229 pages)
附註:
Source: Dissertations Abstracts International, Volume: 86-02, Section: A.
Contained By:
Dissertations Abstracts International86-02A.
標題:
Genetics. -
電子資源:
https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31486140
ISBN:
9798383624296
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment /
Sosa, Eric Alexander,
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment /
Eric Alexander Sosa. - 1 electronic resource (229 pages)
Source: Dissertations Abstracts International, Volume: 86-02, Section: A.
Non-coding variants (NCVs) represent a distinctive and understudied type of genetic variation beyond alterations in the coding regions of our DNA and an increasingly valuable area of research. The non-coding genome is significantly larger than its protein-coding counterpart and requires strategical analyses for variant prioritization. The large number of NCVs and limited knowledge of regulatory elements challenges our ability to prioritize and characterize pathogenic variants from background noise. This thesis explores the intricate interplay between de novo variants (DNVs) and chromatin through a computational genomics framework, enriching our understanding of NCVs in autism -a trait for which limited diagnostic success rates stem in part from our inability to interpret non-coding variation. This thesis reviews the parameters that best predict the contribution(s) of NCVs, introduces a toolkit for the analysis of variant enrichment across cell-specific chromatin architecture, and establishes a link between non-coding variants and intellectual impairment in autism. The timing of this thesis is critical given the evolving feasibility of whole genome sequencing (WGS) technologies for unresolved diseases in the clinical setting.Chapter I provides an overview to understand DNA sequence variation at non-coding regulatory elements and reviews the range of mechanisms by which they alter gene expression and contribute to rare disease. It highlights specific case studies that elucidate functionality in non-coding regions and discusses their interpretation for clinical application through computational methods. This chapter reviews the role of non-coding variants in autism development, the current challenges in predicting their functional consequences, and considerations for strategical prioritization.Chapter II discusses the need for computational toolkits that integrate context-specific chromatin data to identify candidate regulatory variants and introduces Regulatory Landscape Enrichment Analysis (RLEA) by GaiaAssociation, a publicly available, comprehensive software for the efficient analysis of variant enrichment across cell-specific chromatin architecture. The strength of RLEA stems from its unique consideration of the local chromatin environment at specific genomic loci, allowing for the analysis of under-explored variants. The incorporation of cell type regulatory landscape analysis is pivotal to realizing the clinical utility in WGS from non-coding variants.Chapter III integrates multiple functional datasets to assess the functionality of ≈709,200 non-coding de novo variants from 5,515 individuals with autism and 3,556 neurotypical individuals. The chapter explores the enrichment of DNVs at loci destined to be cis-regulatory, driven by C>T transitions in CG dinucleotide contexts, with the preferential occurrence of DNVs in cis-regulatory loci of brain cells near implicated autism genes, and provides an updated category-wide association studies (CWAS) approach that highlights glutamatergic neurons and cells expressed at the mid-fetal stage of development as mediative cell types in intellectual impairment. These data suggest that de novo events in regulatory regions contribute to the genomic architecture of autism and highlight the potential of this approach for understanding non-coding risks across other genomic traits.The Conclusions section discusses the advantages and limitations of these studies in the interpretation of non-coding variants. It explores how these findings may influence the clinical interpretation of non-coding events and serve as a practical tool for clinical application and prediction in the future. The data provided here offer a valuable insight for variant characterization and will facilitate the identification of novel associations between regulatory elements and non-coding variants.
English
ISBN: 9798383624296Subjects--Topical Terms:
530508
Genetics.
Subjects--Index Terms:
Autism
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment /
LDR
:05428nmm a22004453i 4500
001
2434735
005
20250930134351.5
006
m o d
007
cr|nu||||||||
008
261011s2026 miu||||||m |||||||eng d
020
$a
9798383624296
035
$a
(MiAaPQD)AAI31486140
035
$a
AAI31486140
040
$a
MiAaPQD
$b
eng
$c
MiAaPQD
$e
rda
100
1
$a
Sosa, Eric Alexander,
$e
author.
$3
3824815
245
1 0
$a
Non-Coding Variants in the Genomic Architecture of Autism and Intellectual Impairment /
$c
Eric Alexander Sosa.
264
1
$a
Ann Arbor :
$b
ProQuest Dissertations & Theses,
$c
2026
300
$a
1 electronic resource (229 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 86-02, Section: A.
500
$a
Advisors: Greally, John M. Committee members: Zheng, Deyou; Castillo, Pablo E.; Soldner, Frank F.; Ye, Kenny Q.; Wasserstein, Melissa P.
502
$b
Ph.D.
$c
Albert Einstein College of Medicine
$d
2026.
520
$a
Non-coding variants (NCVs) represent a distinctive and understudied type of genetic variation beyond alterations in the coding regions of our DNA and an increasingly valuable area of research. The non-coding genome is significantly larger than its protein-coding counterpart and requires strategical analyses for variant prioritization. The large number of NCVs and limited knowledge of regulatory elements challenges our ability to prioritize and characterize pathogenic variants from background noise. This thesis explores the intricate interplay between de novo variants (DNVs) and chromatin through a computational genomics framework, enriching our understanding of NCVs in autism -a trait for which limited diagnostic success rates stem in part from our inability to interpret non-coding variation. This thesis reviews the parameters that best predict the contribution(s) of NCVs, introduces a toolkit for the analysis of variant enrichment across cell-specific chromatin architecture, and establishes a link between non-coding variants and intellectual impairment in autism. The timing of this thesis is critical given the evolving feasibility of whole genome sequencing (WGS) technologies for unresolved diseases in the clinical setting.Chapter I provides an overview to understand DNA sequence variation at non-coding regulatory elements and reviews the range of mechanisms by which they alter gene expression and contribute to rare disease. It highlights specific case studies that elucidate functionality in non-coding regions and discusses their interpretation for clinical application through computational methods. This chapter reviews the role of non-coding variants in autism development, the current challenges in predicting their functional consequences, and considerations for strategical prioritization.Chapter II discusses the need for computational toolkits that integrate context-specific chromatin data to identify candidate regulatory variants and introduces Regulatory Landscape Enrichment Analysis (RLEA) by GaiaAssociation, a publicly available, comprehensive software for the efficient analysis of variant enrichment across cell-specific chromatin architecture. The strength of RLEA stems from its unique consideration of the local chromatin environment at specific genomic loci, allowing for the analysis of under-explored variants. The incorporation of cell type regulatory landscape analysis is pivotal to realizing the clinical utility in WGS from non-coding variants.Chapter III integrates multiple functional datasets to assess the functionality of ≈709,200 non-coding de novo variants from 5,515 individuals with autism and 3,556 neurotypical individuals. The chapter explores the enrichment of DNVs at loci destined to be cis-regulatory, driven by C>T transitions in CG dinucleotide contexts, with the preferential occurrence of DNVs in cis-regulatory loci of brain cells near implicated autism genes, and provides an updated category-wide association studies (CWAS) approach that highlights glutamatergic neurons and cells expressed at the mid-fetal stage of development as mediative cell types in intellectual impairment. These data suggest that de novo events in regulatory regions contribute to the genomic architecture of autism and highlight the potential of this approach for understanding non-coding risks across other genomic traits.The Conclusions section discusses the advantages and limitations of these studies in the interpretation of non-coding variants. It explores how these findings may influence the clinical interpretation of non-coding events and serve as a practical tool for clinical application and prediction in the future. The data provided here offer a valuable insight for variant characterization and will facilitate the identification of novel associations between regulatory elements and non-coding variants.
546
$a
English
590
$a
School code: 2041
650
4
$a
Genetics.
$3
530508
650
4
$a
Bioinformatics.
$3
553671
650
4
$a
Computer science.
$3
523869
650
4
$a
Disability studies.
$3
543687
653
$a
Autism
653
$a
Cell-type prioritization
653
$a
Chromatin architecture
653
$a
Non-coding variation
653
$a
Intellectual impairment
690
$a
0369
690
$a
0715
690
$a
0984
690
$a
0201
710
2
$a
Albert Einstein College of Medicine.
$b
Biomedical Science.
$e
degree granting institution.
$3
3770386
720
1
$a
Greally, John M.
$e
degree supervisor.
773
0
$t
Dissertations Abstracts International
$g
86-02A.
790
$a
2041
791
$a
Ph.D.
792
$a
2026
856
4 0
$u
https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31486140
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9530430
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入